Division of Hematology, Oncology and Transplantation

  • Committed to providing the highest quality care based on cutting edge research to patients with cancer or non-malignant hematologic diseases such as sickle cell disease

  • Dedicated to advancing research on the biological underpinnings of cancer, stem cell biology, sickle cell anemia, endothelial cell biology, and tumor immunology

  • Over 50 full-time academic investigators involved in interdisciplinary research and patient care are devoted to training the next generation of academic leaders


Armin Rashidi, MD, PhD, received an Institutional Research Grant from the American Cancer Society. With the support of this grant, Dr. Rashidi will lead a translational study to determine whether genetic risk factors contribute to microbiota imbalances in patients who develop acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation. By identifying genetic risk factors for acute GVHD, Dr. Rashidi and his team will be able to use personalized genetic testing to identify transplant recipients eligible for novel clinical interventions to prevent acute GVHD. Please join us in congratulating Dr. Rashidi on receiving this award. May 2018